OBJECTIVE: The purpose of this study was to assess the role of macrophage OSBP-related protein 1L (ORP1L) in the development of atherosclerosis. METHODS AND RESULTS: C57BL/6 mice overexpressing human ORP1L in macrophages driven by scavenger receptor A promoter were generated. Bone marrow (BM) of the mice was transplanted into LDLr-/- animals, and aortic root lesion area in the recipients was determined after Western-type diet feeding. The recipients of ORP1L BM displayed 2.1-fold increase (P<0.001) in lesion size as compared with recipients of wild-type littermate BM. Macrophages of the ORP1L BM recipients showed a decrease in ABCG1 and APOE mRNAs and proteins, and an increase in PLTP message; also the plasma PLTP activity was elevated. The effect of ORP1L on cholesterol efflux was assessed using macrophages loaded with [3H]cholesterol oleate-acLDL or labeled with [3H]cholesterol. The ORP1L transgenic macrophages displayed 30% reduction (P<0.01) in cholesterol efflux to HDL2, but not to apoA-I. ORP1L was shown to bind 25- and 22(R)-hydroxycholesterol, identifying it as an oxysterol binding protein. Furthermore, ORP1L attenuated the response of ABCG1 mRNA to 22(R)-hydroxycholesterol, the effect on ABCA1 being less pronounced. CONCLUSIONS: The results demonstrate that macrophage ORP1L can act as a modulator of atherosclerotic lesion development and provide clues to the underlying mechanism.
OBJECTIVE: The purpose of this study was to assess the role of macrophage OSBP-related protein 1L (ORP1L) in the development of atherosclerosis. METHODS AND RESULTS: C57BL/6 mice overexpressing human ORP1L in macrophages driven by scavenger receptor A promoter were generated. Bone marrow (BM) of the mice was transplanted into LDLr-/- animals, and aortic root lesion area in the recipients was determined after Western-type diet feeding. The recipients of ORP1L BM displayed 2.1-fold increase (P<0.001) in lesion size as compared with recipients of wild-type littermate BM. Macrophages of the ORP1L BM recipients showed a decrease in ABCG1 and APOE mRNAs and proteins, and an increase in PLTP message; also the plasma PLTP activity was elevated. The effect of ORP1L on cholesterol efflux was assessed using macrophages loaded with [3H]cholesterol oleate-acLDL or labeled with [3H]cholesterol. The ORP1L transgenic macrophages displayed 30% reduction (P<0.01) in cholesterol efflux to HDL2, but not to apoA-I. ORP1L was shown to bind 25- and 22(R)-hydroxycholesterol, identifying it as an oxysterol binding protein. Furthermore, ORP1L attenuated the response of ABCG1 mRNA to 22(R)-hydroxycholesterol, the effect on ABCA1 being less pronounced. CONCLUSIONS: The results demonstrate that macrophage ORP1L can act as a modulator of atherosclerotic lesion development and provide clues to the underlying mechanism.
Authors: Sungsoo Lee; Ping-Yuan Wang; Yangsik Jeong; David J Mangelsdorf; Richard G W Anderson; Peter Michaely Journal: Exp Cell Res Date: 2012-06-20 Impact factor: 3.905
Authors: Anthony W G Burgett; Thomas B Poulsen; Kittikhun Wangkanont; D Ryan Anderson; Chikako Kikuchi; Kousei Shimada; Shuichi Okubo; Kevin C Fortner; Yoshihiro Mimaki; Minpei Kuroda; Jason P Murphy; David J Schwalb; Eugene C Petrella; Ivan Cornella-Taracido; Markus Schirle; John A Tallarico; Matthew D Shair Journal: Nat Chem Biol Date: 2011-08-07 Impact factor: 15.040
Authors: Anna V Justis; Bryan Hansen; Paul A Beare; Kourtney B King; Robert A Heinzen; Stacey D Gilk Journal: Cell Microbiol Date: 2016-07-15 Impact factor: 3.715
Authors: Mireille Ouimet; Elizabeth J Hennessy; Coen van Solingen; Graeme J Koelwyn; Maryem A Hussein; Bhama Ramkhelawon; Katey J Rayner; Ryan E Temel; Ljubica Perisic; Ulf Hedin; Lars Maegdefessel; Michael J Garabedian; Lesca M Holdt; Daniel Teupser; Kathryn J Moore Journal: Arterioscler Thromb Vasc Biol Date: 2016-03-03 Impact factor: 8.311
Authors: Julia Perttilä; Krista Merikanto; Jussi Naukkarinen; Ida Surakka; Nicolas W Martin; Kimmo Tanhuanpää; Vinciane Grimard; Marja-Riitta Taskinen; Christoph Thiele; Veikko Salomaa; Antti Jula; Markus Perola; Ismo Virtanen; Leena Peltonen; Vesa M Olkkonen Journal: J Mol Med (Berl) Date: 2009-06-25 Impact factor: 4.599